Your institution may have access to this item. Find your institution then sign in to continue.
Title
CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis.
Authors
Holmes, Michael V; Perel, Pablo; Shah, Tina; Hingorani, Aroon D; Casas, Juan P
Abstract
The US Food and Drug Administration recently recommended that CYP2C19 genotyping be considered prior to prescribing clopidogrel, but the American Heart Association and American College of Cardiologists have argued evidence is insufficient to support CYP2C19 genotype testing.